Product Overview
Kisspeptin 10
Kisspeptin is a hypothalamic neuropeptide that drives the hypothalamic–pituitary–gonadal (HPG) axis by activating GnRH neurons via the kisspeptin receptor KISS1R. ARC KNDy (kisspeptin/neurokinin B/dynorphin) neurons serve as the physiological GnRH pulse generator, integrating sex-steroid feedback and metabolic inputs.[1–6]
Reproductive Physiology & Clinical Applications
- Essential for puberty, menstrual cyclicity, ovulation, and fertility in all sexes; loss-of-function causes congenital hypogonadotropic hypogonadism and infertility.[1–6]
- Exogenous kisspeptin acutely stimulates LH/FSH secretion and LH pulse frequency in healthy adults and in hypothalamic amenorrhea/hypogonadotropic hypogonadism.[2–6,9,10]
- IVF applications: kisspeptin-based oocyte maturation protocols show physiologic GnRH-axis activation with reduced OHSS risk versus hCG in early studies.[7–10]
- Functional hypogonadism & diagnostics: chronic/serial dosing is under investigation to restore reproductive function; diagnostic utility explored for delayed puberty and hypothalamic disorders.[7–10]
Metabolic & Behavioral Effects
- Energy balance: KISS1/KISS1R are expressed in adipose, pancreas, liver, and BAT; knockout models show increased adiposity and reduced energy expenditure.[3,11,12]
- Glucose homeostasis: data suggest potentiation of glucose-stimulated insulin secretion and weight-modulatory, sexually dimorphic effects.[11,12]
- Additional roles: sexual behavior/attraction circuits, placental function, and bone health have emerging evidence.[1,3,8,11]
Therapeutic Potential & Safety
- Analog development: longer-acting kisspeptin analogs aim to overcome short half-life and tachyphylaxis for sustained GnRH drive.[7,8,10]
- Targets: reproductive disorders (hypogonadism, hypothalamic amenorrhea, PCOS) and hypothalamic function testing.[7–10]
- Safety: favorable profile in clinical studies at physiologic/pharmacologic doses; significant adverse effects uncommon to date.[7–10]
Key Takeaways
- Master HPG regulator: KNDy-driven GnRH pulse generation underpins puberty and fertility.
- Clinical momentum: acute LH/FSH stimulation, IVF triggering strategies, and diagnostic applications are advancing.
- Beyond reproduction: metabolic and behavioral effects broaden translational potential.
References
- Koysombat K, Tsoutsouki J, Patel AH, et al. Physiol Rev. 2025;105(2):707–764. doi:10.1152/physrev.00015.2024.[1]
- Xie Q, Kang Y, Zhang C, et al. Front Endocrinol. 2022;13:925206. doi:10.3389/fendo.2022.925206.[2]
- Harter CJL, Kavanagh GS, Smith JT. J Endocrinol. 2018;238(3):R173–R183. doi:10.1530/JOE-18-0108.[3]
- Ruohonen ST, Poutanen M, Tena-Sempere M. Fertil Steril. 2020;114(3):465–474. doi:10.1016/j.fertnstert.2020.06.038.[4]
- Skorupskaite K, George JT, Anderson RA. Hum Reprod Update. 2014;20(4):485–500. doi:10.1093/humupd/dmu009.[5]
- Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Physiol Rev. 2012;92(3):1235–1316. doi:10.1152/physrev.00037.2010.[6]
- Abbara A, Clarke SA, Dhillo WS. Trends Mol Med. 2021;27(8):807–823. doi:10.1016/j.molmed.2021.05.008.[7]
- Patel B, Koysombat K, Mills EG, et al. Endocr Rev. 2024;45(1):30–68. doi:10.1210/endrev/bnad023.[8]
- Hunjan T, Abbara A. Semin Reprod Med. 2019;37(3):119–124. doi:10.1055/s-0039-3400240.[9]
- Tsoutsouki J, Abbara A, Dhillo W. Curr Opin Pharmacol. 2022;67:102319. doi:10.1016/j.coph.2022.102319.[10]
- Izzi-Engbeaya C, Dhillo WS. J Physiol. 2022;600(5):1079–1088. doi:10.1113/JP281712.[11]
- Hudson AD, Kauffman AS. Pharmacol Ther. 2022;231:107974. doi:10.1016/j.pharmthera.2021.107974.[12]
All information provided is for research purposes only.
All COA’s available upon request: info@truformlabs.com
All information provided is for research purposes only.
Storage & Handling (Research Use)
- Lyophilized powder: Store sealed at −20 °C to −80 °C (desiccated, light-protected). Short-term (≤2–3 weeks) at 2–8 °C is acceptable.
- After reconstitution: Store at 2–8 °C and use within 7 days, or aliquot and freeze at −20 °C to −80 °C for ≤3 months.
- Handling: Prepare small aliquots to avoid freeze–thaw; keep on ice during prep; minimize air/light exposure.
- Vehicle & pH: Reconstitute per lot guidance (e.g., sterile saline/BWFI) near pH 7.0–7.4; avoid reactive metals/oxidants.
- Labeling: Record concentration, solvent, and prep date; follow lab SOPs and lot-specific stability notes.
All information provided is for research purposes only.